OTC Monograph User Fee Goals Document Beats Authorization To Finish Line
This article was originally published in The Pink Sheet
Executive Summary
While still awaiting the addition of OTC user fees to pending user fee authorization, and congressional approval of the overall package, FDA has developed guidelines closely tracking Sens. Isakson and Casey's OTC proposal. FDA plans a webinar to update industry on how OTC user fees would work.